Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Unterrainer

Showing results (361-370 of 459) with videos related to

Pageof 46
Sort By:
EJNMMI Physics|February 9, 2023
Investigation of image-based lesion and kidney dosimetry protocols for <sup>177</sup>Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisitionSandra Resch, Sarah Takayama Fouladgar, Mathias Zacherl, et al.
Clinical Nuclear Medicine|March 30, 2021
PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATEMarcus Unterrainer, Simon Lindner, Leonie Beyer, et al.
Neuro-Oncology|February 29, 2020
Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patientsVeit M Stoecklein, Sophia Stoecklein, Franziska Galiè, et al.
Frontiers in Neuroscience|July 6, 2016
Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric ApproachesAdrien Holzgreve, Matthias Brendel, Song Gu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2018
TSPO PET with [<sup>18</sup>F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosisMarcus Unterrainer, C Mahler, L Vomacka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2020
<sup>18</sup>F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary resultsL M Mittlmeier, M Unterrainer, S Rodler, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on <sup>18</sup>F-PSMA-1007 PET/CT Due to Endothelial PSMA-ExpressionLena M Mittlmeier, Stephan T Ledderose, Melanie Schott, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 15, 2023
Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteriaMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
European Journal of Radiology|December 10, 2024
Replication study of PD-L1 status prediction in NSCLC using PET/CT radiomicsAnna Theresa Stüber, Maurice M Heimer, Johanna Ta, et al.
Frontiers in Neurology|January 10, 2018
<i>In Vivo</i> Imaging of Glial Activation after Unilateral Labyrinthectomy in the Rat: A [<sup>18</sup>F]GE180-PET StudyAndreas Zwergal, Lisa Günther, Matthias Brendel, et al.
Pageof 46

Showing results (361-370 of 459) with videos related to

Sort By:
Pageof 46
EJNMMI Physics|February 9, 2023
Investigation of image-based lesion and kidney dosimetry protocols for <sup>177</sup>Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisitionSandra Resch, Sarah Takayama Fouladgar, Mathias Zacherl, et al.
Clinical Nuclear Medicine|March 30, 2021
PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATEMarcus Unterrainer, Simon Lindner, Leonie Beyer, et al.
Neuro-Oncology|February 29, 2020
Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patientsVeit M Stoecklein, Sophia Stoecklein, Franziska Galiè, et al.
Frontiers in Neuroscience|July 6, 2016
Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric ApproachesAdrien Holzgreve, Matthias Brendel, Song Gu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2018
TSPO PET with [<sup>18</sup>F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosisMarcus Unterrainer, C Mahler, L Vomacka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2020
<sup>18</sup>F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary resultsL M Mittlmeier, M Unterrainer, S Rodler, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on <sup>18</sup>F-PSMA-1007 PET/CT Due to Endothelial PSMA-ExpressionLena M Mittlmeier, Stephan T Ledderose, Melanie Schott, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 15, 2023
Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteriaMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
European Journal of Radiology|December 10, 2024
Replication study of PD-L1 status prediction in NSCLC using PET/CT radiomicsAnna Theresa Stüber, Maurice M Heimer, Johanna Ta, et al.
Frontiers in Neurology|January 10, 2018
<i>In Vivo</i> Imaging of Glial Activation after Unilateral Labyrinthectomy in the Rat: A [<sup>18</sup>F]GE180-PET StudyAndreas Zwergal, Lisa Günther, Matthias Brendel, et al.
Pageof 46